# Lunsumio

NDC: 50242-159
Generic name: Mosunetuzumab
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20221222

FDA application: BLA761263

## Active ingredients

- MOSUNETUZUMAB: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-159"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-159
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ef0cf38-101c-4681-98fe-c05dc9ead443